B pembrolizumab

Lingjie Hou1,2,3,4,5, Siyuan Zhang1,2,3,4,5, Wenwen Yu1,2,3,4,5

  • 1National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, No. 45 Binshui Road, Hexi District, Tianjin 300060, China.

PubMed
概括

这项研究表明,记忆B细胞和G蛋白结合受体183与接受新辅助化疗免疫治疗的非小细胞肺癌 (NSCLC) 患者的积极结果有关.